Latest News TearScience Names Joseph Boorady CEO By Staff Monday, March 2, 2015 12:24 AM Joseph Boorady. MORRISVILLE, N.C.— TearScience, a privately held medical device company, has named Joseph Boorady president and CEO. Dr. Boorady joins TearScience from Carl Zeiss Meditec, Inc. where he was senior vice president of U.S. sales, marketing, and customer service for all medical products. TearScience current CEO and co-founder Tim Willis, will turn over CEO duties. “Boorady’s professional expertise and commercial track record make him the ideal candidate to lead TearScience to the next level,” said Willis. “TearScience technology has already improved care for tens of thousands suffering from Meibomian Gland Dysfunction (MGD), with significant opportunity for ongoing education and treatment to help millions with the disease. Joe’s proven industry expertise will provide the energy to vastly expand use of the breakthrough LipiView II and LipiFlow devices.” Boorady’s more than 20 years in the industry as an eyecare professional, educational leader, entrepreneur and corporate executive began after graduating in 1993 from the State University of New York (SUNY) College of Optometry with clinical honors. He has 13 years of clinical experience as the founder and owner of several primary eyecare practices in New York and New Jersey, and 10 years with SUNY College of Optometry, where his last position was vice president clinical affairs and executive director overseeing 36 clinics throughout New York City. Boorady then spent three years as an equity partner and COO of an eyecare software start-up. He also became an alumnus of the Harvard Business School, finally joining Carl Zeiss Meditec in 2009 where he led significant U.S. growth at the ophthalmic technology giant.